| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |